555 Madison Avenue Suite 1201,
New York, New York 10022
United States
(212) 257-5801
www.torreyapartners.com
Torreya Partners LLC is a boutique advisory firm focused on providing strategic advice and assistance to clients from the life science sector worldwide. The Firm's practice areas include mergers and acquisitions advisory, divestitures, financial restructuring, and fairness opinions. Torreya Partners was formed in 2007 and is based in New York City.
| Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T |
|---|---|---|---|---|---|---|---|
| Buyside (0.2/yr) | 4 | - | - | - | 1 | - | 5 |
| Sellside (0.6/yr) | 16 | - | 2 | 1 | - | - | 19 |
| 24 | |||||||
| Target Company | Date | Value | Type |
|---|---|---|---|
| Sign-up to View | 2023-02-23 | - | Life Science |
| Sign-up to View | 2022-08-24 | - | Life Science |
| Sign-up to View | 2021-05-05 | - | Life Science |
| Sign-up to View | 2021-03-31 | - | Medical Products |
| Sign-up to View | 2019-04-04 | - | Business Services |
| Sign-up to View | 2018-03-28 | 61M USD | Life Science |
| Sign-up to View | 2017-10-30 | - | Life Science |
| Sign-up to View | 2017-07-31 | 33M USD | Life Science |
| Sign-up to View | 2017-04-20 | 1.1B USD | Life Science |
| Sign-up to View | 2016-12-29 | - | Medical Products |
| View All >> | |||
| Sector | # | Value | |
|---|---|---|---|
| Life Science | Sign-up to View | ||
| Medical Products | Sign-up to View | ||
| Healthcare Services | Sign-up to View | ||
| Business Services | Sign-up to View | ||
| Total | Sign-up to View | ||
| State/Country | # | Value | |
|---|---|---|---|
| United States | Sign-up to View | ||
| California | Sign-up to View | ||
| Massachusetts | Sign-up to View | ||
| New York | Sign-up to View | ||
| Pennsylvania | Sign-up to View | ||
| Minnesota | Sign-up to View | ||
| North Carolina | Sign-up to View | ||
| India | Sign-up to View | ||
| Australia | Sign-up to View | ||
| Switzerland | Sign-up to View | ||
| Canada | Sign-up to View | ||
| United Kingdom | Sign-up to View | ||
| Domestic | Sign-up to View | ||
| Cross-border | Sign-up to View | ||
| Total | Sign-up to View | ||
| Type | # | Value | |
|---|---|---|---|
| Add-on Acquisition | Sign-up to View | ||
| Merger | Sign-up to View | ||
| Divestiture | Sign-up to View | ||
| Growth Capital | Sign-up to View | ||
| Going Private | Sign-up to View | ||
| Stake Purchase | Sign-up to View | ||
| Total | Sign-up to View | ||
| PE Firms (1) | Deals |
|---|---|
|
Sign-up to View |
1 |
| Corporate (24) | Deals |
|---|---|
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
| Value | # | TOTAL |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
Upsher-Smith Laboratories, Inc. - Generics Business $1.1B (2017-04-20) |
|
